D.O. 0002 (option 2)

Ended Awarded Oct 1, 2014 Last action May 1, 2020

Contract number: 0002
Awardee: Diagnostic Hybrids Inc. UEI SWUKAJ3C95L1 Part of Quidel Corp
Awarding agency: Medical Command Department of the Army, Department of Defense
Obligated: $114,213

Award facts

Contract value 100% obligated: $114,212.65 Current and potential, with all options
Completion date 100% complete: Sep 30, 2015 Current and potential, with all options
NAICS code: 325413 In-Vitro Diagnostic Substance Manufacturing
PSC: 6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside: No set-aside
Competition: Not Competed Only One Source
Pricing: Firm Fixed Price
Place of performance: Athens, OH 45701, USA

Award details come from SAM.gov/FPDS.

Action	Obligated	Date
Close Out 2 · D3 fastpoint resp virus ID kit - deobligate FY15 funds for closeout modification	-$45,612	May 1, 2020
Funding Only Action 1 · MOD to release FY15 funds, D3 fastpoint resp virus ID kit	$159,825	Oct 10, 2014
Original award	$0	Aug 6, 2014

0002 was awarded to Diagnostic Hybrids Inc. by Medical Command (Department of the Army) on October 1, 2014.

The government has obligated $114,213 on 0002.

Yes. 0002 is a delivery order under W81K0213DM001, an indefinite delivery contract.

The extent of competition for 0002 was not competed.

On GovTribe

Try for free Login